Hypera SA (HYPMY)
Company Info
Highlights
$2.79B
$0.22
19.14
$6.70B
$3.78B
$1.43B
$2.56 - $5.70
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
Loading data...
Returns By Period
Hypera SA (HYPMY) returned 44.48% year-to-date (YTD) and -16.17% over the past 12 months. Over the past 10 years, HYPMY returned -0.86% annually, underperforming the S&P 500 benchmark at 10.84%.
HYPMY
44.48%
7.25%
33.17%
-16.17%
-16.41%
-3.38%
-0.86%
^GSPC (Benchmark)
0.52%
6.32%
-1.44%
12.25%
12.45%
14.20%
10.84%
Monthly Returns
The table below presents the monthly returns of HYPMY, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 2.58% | 5.18% | 3.54% | 11.85% | 15.63% | 44.48% | |||||||
| 2024 | -11.73% | 13.04% | -5.48% | -9.93% | -14.99% | 3.14% | -4.63% | 0.23% | -1.08% | -22.95% | -14.85% | -4.67% | -55.96% |
| 2023 | 8.09% | -15.75% | -3.79% | 2.60% | 8.14% | 18.70% | -4.10% | -15.35% | -3.71% | -17.22% | 13.40% | 4.04% | -11.90% |
| 2022 | 17.72% | 5.71% | 29.73% | -0.71% | 1.26% | -12.57% | 15.60% | 1.98% | -0.12% | 16.34% | -13.59% | 3.02% | 73.07% |
| 2021 | -9.21% | -2.84% | -2.87% | 13.21% | 9.86% | -0.78% | 1.47% | -1.30% | -12.77% | -16.24% | -3.04% | 5.64% | -20.77% |
| 2020 | -7.77% | -9.15% | -32.82% | 5.66% | 15.74% | -2.12% | 15.11% | -15.14% | -9.54% | -5.81% | 18.13% | 13.81% | -24.60% |
| 2019 | 10.85% | -16.34% | -7.96% | 9.28% | 6.78% | 2.54% | 0.44% | -0.64% | 3.16% | 6.31% | -7.53% | 15.97% | 19.88% |
| 2018 | 7.99% | -7.27% | 1.40% | -15.89% | -15.71% | -8.36% | 5.48% | -8.84% | 3.88% | 14.11% | 5.26% | -5.16% | -24.93% |
| 2017 | 13.29% | 0.38% | 5.00% | 2.19% | -2.15% | -4.16% | 6.70% | 4.55% | 8.39% | 2.94% | -4.47% | 9.41% | 48.86% |
| 2016 | 2.77% | 14.51% | 22.92% | 10.99% | -10.02% | -6.90% | 18.53% | -5.90% | 7.80% | -3.05% | -9.55% | 4.64% | 48.39% |
| 2015 | 9.43% | -2.88% | -6.57% | 10.20% | 1.83% | 4.66% | -15.89% | -23.78% | -18.51% | 20.56% | 24.18% | -5.08% | -13.42% |
| 2014 | -17.44% | 1.12% | 14.72% | 2.48% | 9.15% | 7.15% | -7.13% | 7.56% | -17.28% | -3.62% | -2.17% | -7.53% | -17.31% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of HYPMY is 30, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Hypera SA (HYPMY) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Loading data...
Dividends
Dividend History
Hypera SA provided a 4.41% dividend yield over the last twelve months, with an annual payout of $0.19 per share.
| Period | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | $0.19 | $0.17 | $0.25 | $0.24 | $0.23 | $0.22 | $0.27 | $0.53 | $0.60 | $0.15 |
Dividend yield | 4.41% | 5.52% | 3.46% | 2.85% | 4.56% | 3.38% | 2.99% | 6.86% | 5.46% | 1.86% |
Monthly Dividends
The table displays the monthly dividend distributions for Hypera SA. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | $0.05 | $0.00 | $0.00 | $0.05 | $0.00 | $0.10 | |||||||
| 2024 | $0.00 | $0.02 | $0.04 | $0.00 | $0.04 | $0.00 | $0.02 | $0.02 | $0.00 | $0.04 | $0.00 | $0.00 | $0.17 |
| 2023 | $0.00 | $0.00 | $0.00 | $0.06 | $0.00 | $0.00 | $0.06 | $0.00 | $0.00 | $0.06 | $0.00 | $0.06 | $0.25 |
| 2022 | $0.00 | $0.00 | $0.00 | $0.06 | $0.00 | $0.00 | $0.06 | $0.00 | $0.00 | $0.06 | $0.00 | $0.06 | $0.24 |
| 2021 | $0.00 | $0.00 | $0.00 | $0.06 | $0.00 | $0.00 | $0.06 | $0.00 | $0.00 | $0.06 | $0.00 | $0.05 | $0.23 |
| 2020 | $0.00 | $0.00 | $0.00 | $0.06 | $0.00 | $0.00 | $0.05 | $0.00 | $0.00 | $0.05 | $0.00 | $0.06 | $0.22 |
| 2019 | $0.00 | $0.00 | $0.00 | $0.07 | $0.00 | $0.00 | $0.07 | $0.00 | $0.00 | $0.06 | $0.00 | $0.08 | $0.27 |
| 2018 | $0.28 | $0.00 | $0.00 | $0.06 | $0.00 | $0.00 | $0.05 | $0.00 | $0.00 | $0.05 | $0.00 | $0.09 | $0.53 |
| 2017 | $0.00 | $0.19 | $0.00 | $0.02 | $0.00 | $0.39 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.60 |
| 2016 | $0.01 | $0.06 | $0.00 | $0.00 | $0.08 | $0.00 | $0.00 | $0.00 | $0.00 | $0.15 |
Dividend Yield & Payout
Dividend Yield
Hypera SA has a dividend yield of 4.41%, which is quite average when compared to the overall market.
Payout Ratio
Hypera SA has a payout ratio of 56.32%, which is quite average when compared to the overall market. This suggests that Hypera SA strikes a balance between reinvesting profits for growth and paying dividends to shareholders.
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading data...
Worst Drawdowns
The table below displays the maximum drawdowns of the Hypera SA. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Hypera SA was 79.35%, occurring on Sep 28, 2015. The portfolio has not yet recovered.
The current Hypera SA drawdown is 64.18%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -79.35% | Oct 13, 2010 | 1099 | Sep 28, 2015 | — | — | — |
| -17.1% | Jun 3, 2010 | 19 | Jul 20, 2010 | 40 | Sep 27, 2010 | 59 |
| -3.85% | Sep 28, 2010 | 2 | Sep 29, 2010 | 1 | Sep 30, 2010 | 3 |
| -0.37% | Oct 11, 2010 | 1 | Oct 11, 2010 | 1 | Oct 12, 2010 | 2 |
| -0.32% | Oct 4, 2010 | 1 | Oct 4, 2010 | 1 | Oct 5, 2010 | 2 |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading data...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Hypera SA over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Earnings Per Share
The chart presents the Earnings Per Share (EPS) performance of Hypera SA, comparing actual results with analytics estimates.
Valuation
The Valuation section provides an overview of how Hypera SA is priced in the market compared to other companies in the Drug Manufacturers - Specialty & Generic industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for HYPMY, comparing it with other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, HYPMY has a P/E ratio of 19.1. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.
PEG Ratio
The chart shows the Price/Earnings to Growth (PEG) ratio for HYPMY compared to other companies in the Drug Manufacturers - Specialty & Generic industry. HYPMY currently has a PEG ratio of 0.0. This PEG ratio is low compared to industry peers, which could indicate the stock is undervalued relative to its expected growth.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for HYPMY relative to other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, HYPMY has a P/S ratio of 0.4. This P/S ratio is low compared to the industry average. It may indicate that the stock is undervalued relative to its revenue, or that the market expects slower growth or lower margins.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for HYPMY in comparison with other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, HYPMY has a P/B value of 1.3. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |